Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124

Section 14.1

Remission — designated COVID-19 drug

Cite as Fees in Respect of Drugs and Medical Devices Order, SOR/2019-124, s. 14.1 · current to July 24, 2025 · regulation last amended May 31, 2025

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

(1) Remission is granted to the person referred to in subsection 9(2) of the amount of the fee that is payable under subsection 9(1) if the person has (a) filed, under the ISAD Interim Order, an application for a designated COVID-19 drug, as defined in section C.08.001.1 of the Food and Drug Regulations as that section read immediately before the day on which subsection 24(1) of the Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Agile Licensing) comes into force; and (b) subsequently filed a submission for that drug. (2) The remission referred to in subsection (1) is granted if the person has not previously filed a submission for that designated COVID-19 drug.
Read the Fees in Respect of Drugs and Medical Devices Order on the Justice Laws Website ↗

Made under Food and Drugs Act, R.S.C. 1985, c. F-27.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.